1
|
Khera AV and Rader DJ: Discovery and
validation of new molecular targets in treating dyslipidemia: the
role of human genetics. Trends Cardiovasc Med. 19:195–201. 2009.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Ordovas JM: Nutrigenetics, plasma lipids,
and cardiovascular risk. J Am Diet Assoc. 106:1074–1081. 2006.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Stamler J, Wentworth D and Neaton JD: Is
relationship between serum cholesterol and risk of premature death
from coronary heart disease continuous and graded? Findings in
356,222 primary screenees of the Multiple Risk Factor Intervention
Trial (MRFIT). JAMA. 256:2823–2828. 1986. View Article : Google Scholar
|
4
|
Pekkanen J, Linn S, Heiss G, Suchindran
CM, Leon A, Rifkind BM and Tyroler HA: Ten-year mortality from
cardiovascular disease in relation to cholesterol level among men
with and without preexisting cardiovascular disease. N Engl J Med.
322:1700–1707. 1990.PubMed/NCBI
|
5
|
Aulchenko YS, Ripatti S, Lindqvist I, et
al: Loci influencing lipid levels and coronary heart disease risk
in 16 European population cohorts. Nat Genet. 41:47–55. 2009.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Kathiresan S, Melander O, Guiducci C, et
al: Six new loci associated with blood low-density lipoprotein
cholesterol, high-density lipoprotein cholesterol or triglycerides
in humans. Nat Genet. 40:189–197. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kathiresan S, Willer CJ, Peloso GM, et al:
Common variants at 30 loci contribute to polygenic dyslipidemia.
Nat Genet. 41:56–65. 2009. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Yamada Y, Nishida T, Ichihara S, et al:
Association of a polymorphism of BTN2A1 with myocardial infarction
in East Asian populations. Atherosclerosis. 215:145–152. 2011.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Yamada Y, Matsuo H, Warita S, et al:
Prediction of genetic risk for dyslipidemia. Genomics. 90:551–558.
2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Itoh Y, Mizuki N, Shimada T, et al:
High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a
PCR-SSOP-Luminex method in the Japanese population. Immunogenetics.
57:717–729. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Smith DG: Epidemiology of dyslipidemia and
economic burden on the healthcare system. Am J Manag Care. 13(Suppl
3): S68–S71. 2007.PubMed/NCBI
|
12
|
World Health Organization. Quantifying
selected major risks to health. The World Health Report 2002 -
Reducting Risks, Promoting Healthy Life. World Health Organization;
Geneva: pp. 47–97. 2002
|
13
|
Fujimaki T, Kato K, Oguri M, et al:
Association of a polymorphism of BTN2A1 with dyslipidemia in East
Asian populations. Exp Ther Med. 2:745–749. 2011.PubMed/NCBI
|
14
|
Ogg SL, Weldon AK, Dobbie L, Smith AJ and
Mather IH: Expression of butyrophilin (Btn1a1) in lactating mammary
gland is essential for the regulated secretion of milk-lipid
droplets. Proc Natl Acad Sci USA. 101:10084–10089. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Arnett HA, Escobar SS and Viney JL:
Regulation of costimulation in the era of butyrophilins. Cytokine.
46:370–375. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Oguri M, Kato K, Yoshida T, et al:
Association of a genetic variant of BTN2A1 with metabolic syndrome
in East Asian populations. J Med Genet. 48:787–792. 2011.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Khovidhunkit W, Kim MS, Memon RA, et al:
Effects of infection and inflammation on lipid and lipoprotein
metabolism: mechanisms and consequences to the host. J Lipid Res.
45:1169–1196. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Esteve E, Ricart W and Frenándes-Real JM:
Dyslipidemia and inflammation: an evolutionary conserved mechanism.
Clin Nutr. 24:16–31. 2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gallin JI, Kaye D and O’Leary WM: Serum
lipids in infection. N Engl J Med. 281:1081–1086. 1969. View Article : Google Scholar : PubMed/NCBI
|
20
|
Sammalkorpi K, Valtonen V, Kerttula Y,
Nikkilä E and Taskinen MR: Changes in serum lipoprotein pattern
induced by acute infections. Metabolism. 37:859–865. 1988.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Chen X, Xun K, Chen L and Wang Y:
TNF-alpha, a potent lipid metabolism regulator. Cell Biochem Funct.
27:407–416. 2009. View
Article : Google Scholar : PubMed/NCBI
|
22
|
McGillicuddy FC, de la Llera Moya M,
Hinkle CC, et al: Inflammation impairs reverse cholesterol
transport in vivo. Circulation. 119:1135–1145. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Reiss AB: Effects of inflammation on
cholesterol metabolism: impact on systemic lupus erythematosus.
Curr Rheumatol Rep. 11:255–260. 2009. View Article : Google Scholar : PubMed/NCBI
|